Overview
- All inclusive formulary for ocular prescription medications
- Including new agents in retinal disease
Access this book
Tax calculation will be finalised at checkout
Other ways to access
About this book
Ophthalmology has long been considered a surgical area because so many disorders/diseases are treated surgically rather than medically. In the past ten years, however, there have been considerable therapeutic breakthroughs in non-surgical treatments. For instance, anti-glaucoma agents have becoming increasingly effective. This edition will include a new chapter for retinal disease. There are now several pharmaceutical agents being used to treat these diseases. Specifically, age-related macular degeneration has many new products – macugen, lucentis, etc. – and intraocular infections are primarily treated with intravitreal medications. Additionally, the anti-allergy and dry eye markets have grown tremendously in the last 2-3 years (endura, restasis, xibrom, etc).
Similar content being viewed by others
Keywords
Table of contents (12 chapters)
-
Front Matter
-
Back Matter
Authors and Affiliations
Bibliographic Information
Book Title: Ophthalmologic Drug Guide
Authors: Douglas J. Rhee, Kathryn A. Colby, Christopher J. Rapuano, Lucia Sobrin
DOI: https://doi.org/10.1007/978-0-387-49964-2
Publisher: Springer New York, NY
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer-Verlag New York 2007
eBook ISBN: 978-0-387-49964-2Published: 06 March 2007
Edition Number: 1
Number of Pages: XII, 142
Topics: Ophthalmology